Rays Power Infra announced closure of INR 127 Crore Equity Capital Fund Raise - Second Act Awards 2026 Celebrate Courage, Reinvention and Meaningful New Beginnings Meenakashi Lekhi attended the Mumbai event as Chief Guest as entrepreneurs, artists and changemakers were honoured for rewriting their life stories - Prestigious Asia’s Modern Hero Award 2026 Dr. Nilesh Potdar Honoured with Asia’s Modern Hero Award 2026 - Maharashtra’s Culture Comes Alive in Berlin as ‘Ganpati Bappa Morya’ Echoes Across the City - Matrimonial Dispute Widens Into Parallel Legal Proceedings Across Delhi and Uttar Pradesh A June 2025 complaint by Ayush Gupta preceded Nikita Jaiswal’s September 2025 Kanpur FIR; subsequent proceedings have brought documentary evidence, competing allegations and judicial scrutiny into the public record - Five-Year-Old Boy with Relapsed Leukemia is Cancer-Free after Haploidentical Bone Marrow Transplant at Kokilaben Hospital, Navi Mumbai - Orient Cables (India) Limited Announced its ₹5,520.00 million Initial Public Offering (IPO) to open on September 25, 2026 Price Band fixed at ₹258 to ₹272 per equity share of face value of ₹1 each - AceVector Limited Announced it's Initial Public Offer (IPO) of Equity Shares to open on September 25, 2026, Price Band is fixed at ₹ 30 to ₹ 32 per equity share of face value of ₹ 1 each - Moneyview Limited announced its Initial public offering (IPO) to open on Thursday, September 24, 2026 Price Band fixed at ₹32 per equity share of face value ₹1 each to ₹34 per equity share of the face value of ₹1 each - Moneyview Limited announced it's Initial public offering (IPO) to open on Thursday, September 24, 2026 Price Band fixed at ₹32 per equity share of face value ₹1 each to ₹34 per equity share of the face value of ₹1 each - BVG India awarded contract of Chambal Riverfront to Develop a Destination for Sustainable Urban Living and Tourism

Mumbai Oncocare Centre raises $ 10 million in Series A funding from Tata Capital Healthcare Fund

Mumbai, January 16, 2023 (GNI): Mumbai Oncocare Centre (MOC), a Chain of Cancer Daycare Centers and a unit of Cellcure Cancer Center Pvt Ltd announced this Saturday that it has raised up to $10 million from Tata Capital Healthcare Fund for an undisclosed equity stake. MOC plans to utilize the newly infused capital to expand across India in next 18 months.

Founded in 2018 by four Medical Oncologist, (Dr Ashish Joshi, Dr Vashishth Maniar, Dr Pritam Kalaskar and Dr Kshitij Joshi), and immensely supported, contributed and co-created by 15 other Medical Oncologists, MOC is a pioneering chain of cancer daycares operational at 16 locations across 10 cities of Maharashtra and Madhya Pradesh.

Speaking on the partnership, Mr. Manish Jobanputra, COO of MOC said, “It is our privilege to join hands with Tata Capital, which is part of the Tata group that has earned and retained a reputation of being the most ethical industrial and business enterprise in India and globally”.

Partner at Tata Capital Healthcare Fund, Mr Vamesh Chovatia says, “MOC is an exciting addition in our healthcare and life science portfolio. As a healthcare focused fund, we were keen to be at the forefront of addressing cancer care and with MOC we found a great partner who are a focused medical oncology services delivery chain. The philosophy and mission of MOC, to provide high quality care at affordable price points aligned with our objective of financing such scalable and profitable business models. MOC is bridging the continuum and making treatments for patients accessible and affordable. We are extremely proud of supporting this young energetic team at MOC and it is a privilege to be a part of their noble journey.

Every year approximately 15 lac people get diagnosed with cancer in India and at any given time there are additional 25-30 lakh cancer patients who are undergoing treatment. Large number of these patients need chemotherapy, immunotherapy, and majority need to consult a medical oncologist during their treatment journey. MOC addresses this unmet need with their unique community daycare centers, which are fully compliant hospitals, where these patients can get personalized, and high-quality care. MOC puts high emphasis on clinical research, technology, and tumor boards where collective wisdom of its oncologists ensure that the care given is always evidence based.ends GNI SG

Be the first to comment on "Mumbai Oncocare Centre raises $ 10 million in Series A funding from Tata Capital Healthcare Fund"

Leave a comment

Your email address will not be published.


*